ClearSight system enables clinicians to reduce risk of post-surgical complications<br />
<br />
IRVINE, CA — Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.<br />
<br />
The ClearSight system is a noninvasive monitor that provides clinicians access to valuable blood volume and blood flow information for ...This story is related to the following:Sensors, Monitors and Transducers Sponsored by: BEI Sensors (BEI Industrial Encoders) - Cat Sponsor Jan 2014 Search for suppliers of: Blood Pressure Monitors